PlexBio Receives CE Mark for PCR-based Coronavirus Detection Kit

By HospiMedica International staff writers
Posted on 05 May 2020

PlexBio Co., Ltd. (Taipei, Taiwan) has received the CE mark for its IntelliPlex SARS-CoV-2 Detection Kit which is now available in European countries.

PlexBio’s PCR-based test detects SARS-CoV-2 in nasopharyngeal swab specimens from patients who may or may not exhibit symptoms of COVID-19. The test runs on the company’s IntelliPlex platform for multiplex assays and can process up to 564 samples within eight hours. The kit leverages the multiplexing capabilities of the IntelliPlex platform by simultaneously detecting the E, N, and RdRp genes in the virus, which mitigates the probability of getting false negative results.